Literature DB >> 31279435

Treatment Options for Melanoma of Gray Horses.

Robert J MacKay1.   

Abstract

All gray horses inherited a single gene mutation, STX17G, that unbalances melanocyte behavior to cause graying and propensities to develop vitiligo and melanoma. The coat color genes ASIPa and MC1RE add risk such that relative likelihood of melanoma based on pregraying coat color is black > bay > chestnut. Melanomas begin at about 4 years. Locoregional control of melanoma masses depends on surgical removal and/or intralesional chemotherapy (possibly with adjunctive hyperthermia or electroporation). Systemic treatment is not evidence based but immunomodulators (cimetidine, levamisole) and vaccines can be tried.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gray horse; Immunotherapy; Melanoma; Treatment; Vaccine

Mesh:

Year:  2019        PMID: 31279435     DOI: 10.1016/j.cveq.2019.04.003

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  1 in total

1.  Differential Gene Expression and Methylation Analysis of Melanoma in TCGA Database to Further Study the Expression Pattern of KYNU in Melanoma.

Authors:  Min Wang; Meng Liu; Yingjian Huang; Ziyang Wang; Yuqian Wang; Ke He; Ruimin Bai; Tingyi Ying; Yan Zheng
Journal:  J Pers Med       Date:  2022-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.